Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J W David Mcgirr

Affiliations

  • Director at Menlo Therapeutics Inc. (MNLO), 2019-08-09
  • Director at Rhythm Pharmaceuticals Inc. (RYTM), 2019-06-21
  • Director at X4 Pharmaceuticals Inc (XFOR), 2019-06-19
  • Director at Insmed Inc (INSM), 2019-05-16
  • Director at Roka Bioscience Inc. (ROKA), 2017-06-30
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • Svp & Chief Financial Officer at Cubist Pharmaceuticals Inc (CBST), 2013-02-20
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ROKA $3.65 20,994 Director 50,000 2014-11-17 Filing
ROKA $3.57 29,006 Director 29,006 2014-11-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYP $19.34 1,013 Director 2,729 2016-06-07 Filing
RLYP $34.67 1,220 Director 3,742 2015-06-11 Filing
CBST $49.79 15,000 Officer 17,200 2012-09-21 Filing
CBST $45.69 20,000 Officer 17,200 2012-08-24 Filing
CBST $42.68 15,000 Officer 17,345 2012-02-23 Filing